Acuvi (ACUVI) Q3 2025 earnings summary

Executive summary

• Revenue for Q3 2025 increased by 32% year-over-year to 58 MSEK, with strong growth momentum continuing into the second half of the year.

• Adjusted EBITDA for Q3 was 8 MSEK, maintaining margin at 14%, while reported EBITDA margin declined to 12% from 18% last year.

• Net income for Q3 was -2.6 MSEK, an improvement from -4.4 MSEK in Q3 2024.

• New CEO Nils Sjöholm appointed in October 2025, emphasizing focus, efficiency, and strategic growth.

Financial highlights

• Q3 net sales: 58 MSEK (44 MSEK in Q3 2024); nine-month sales: 151 MSEK (135 MSEK in 2024).

• Q3 EBITDA: 7 MSEK (8 MSEK); adjusted EBITDA: 8 MSEK (8 MSEK).

• Q3 EBIT: 1.2 MSEK (5.8 MSEK); net result per share: -0.08 SEK (-0.15 SEK).

• Gross margin for Q3 improved to 60% (58%).

• Cash and cash equivalents at quarter-end: 41.1 MSEK.

Outlook and guidance

• Management expects the historical trend of a stronger second half to continue.

• Strategic plan for 2025–2028 updated, focusing on scaling product portfolio and commercial structure.